![](/img/cover-not-exists.png)
A Phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
Angela Dispenzieri, Gregory A. Wiseman, Martha Q. Lacy, Suzanne R. Hayman, Shaji K. Kumar, Francis Buadi, David Dingli, Krista M. Laumann, Jake Allred, Susan M. Geyer, Mark R. Litzow, Dennis A. GastinVolume:
85
Year:
2010
Language:
english
Pages:
1
DOI:
10.1002/ajh.21696
File:
PDF, 162 KB
english, 2010